Intensive chemoradiotherapy damages the mucosal barrier of the mouth and throat and is often associated with severe oral inflammation and infection. This study examined the use of a 0.12% chlorhexidine gluconate mouthrinse for prophylaxis against oral complications in patients receiving bone marrow transplants. Use of chlorhexidine mouthrinse produced reductions in oral soft tissue disease and oral microbial burden, including a significant decrease in oral mucositis and Candida infections. The advantage for patients undergoing intensive antineoplastic therapy, and potentially for other immunocompromised patients susceptible to oral infections, was studied.

This article has been cited by other articles:

				K. Lotfi-Jam, M. Carey, M. Jefford, P. Schofield, C. Charleson, and S. Aranda Nonpharmacologic Strategies for Managing Common Chemotherapy Adverse Effects: A Systematic Review J. Clin. Oncol., December 1, 2008; 26(34): 5618 - 5629. [Abstract] [Full Text] [PDF]

				H. J. Durivage and N. L. Burnham Prevention and Management of Toxicities Associated With Antineoplastic Drugs Journal of Pharmacy Practice, January 1, 1991; 4(1): 27 - 48. [PDF]